These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 8321293

  • 1. FDA joins market.
    Gershon D.
    Nature; 1993 Jul 08; 364(6433):93. PubMed ID: 8321293
    [No Abstract] [Full Text] [Related]

  • 2. Paying for drug approvals--who's using whom?
    Avorn J.
    N Engl J Med; 2007 Apr 26; 356(17):1697-700. PubMed ID: 17435083
    [No Abstract] [Full Text] [Related]

  • 3. Drug safety reform at the FDA--pendulum swing or systematic improvement?
    McClellan M.
    N Engl J Med; 2007 Apr 26; 356(17):1700-2. PubMed ID: 17435081
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration?
    Zelenay JL.
    Food Drug Law J; 2005 Apr 26; 60(2):261-338. PubMed ID: 16094773
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. User fees to fund faster reviews.
    Henkel J.
    FDA Consum; 1993 Oct 26; 27(8):19-21. PubMed ID: 10129049
    [No Abstract] [Full Text] [Related]

  • 13. What ails the FDA?
    Okie S.
    N Engl J Med; 2005 Mar 17; 352(11):1063-6. PubMed ID: 15784660
    [No Abstract] [Full Text] [Related]

  • 14. Vouchers for FDA priority reviews.
    Spatz ID.
    Health Aff (Millwood); 2006 Mar 17; 25(4):1184; author reply 1184-5. PubMed ID: 16835203
    [No Abstract] [Full Text] [Related]

  • 15. Food and Drug Administration.
    Horton LR.
    BMJ; 2007 Jan 13; 334(7584):55-6. PubMed ID: 17218671
    [Abstract] [Full Text] [Related]

  • 16. FDA user fees and innovation.
    Somberg J.
    Am J Ther; 2008 Jan 13; 15(2):97. PubMed ID: 18356626
    [No Abstract] [Full Text] [Related]

  • 17. User fees and beyond--the FDA Safety and Innovation Act of 2012.
    Kramer DB, Kesselheim AS.
    N Engl J Med; 2012 Oct 04; 367(14):1277-9. PubMed ID: 23034017
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Balancing US patent and FDA approval processes: strategically optimizing market exclusivity.
    Fernandez DS, Huie JT.
    Drug Discov Today; 2004 Jun 15; 9(12):509-12. PubMed ID: 15183155
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.